Evidence-based cost-benefit analysis of Ginkgo Biloba.
Ginkgo biloba extract EGb 761 has shown to be safe and effective in the treatment of mild dementia, potentially improving cognitive function and quality of life in affected individuals. The extract may help in managing symptoms associated with mild cognitive impairment.
Individuals experiencing mild dementia or cognitive decline may benefit most from Ginkgo biloba supplementation. It is important to consult with a healthcare provider before starting any new supplement regimen, especially for those with existing medical conditions or taking medications.
While Ginkgo biloba extract EGb 761 has shown promise in improving cognitive function, it is important to note that individual responses may vary. Some individuals may experience side effects such as gastrointestinal disturbances or allergic reactions. Additionally, Ginkgo biloba may interact with certain medications, particularly blood thinners, so it is crucial to discuss its use with a healthcare provider. Long-term safety and efficacy beyond the studied conditions may require further research.
Compare other supplements by cost and evidence
Educational and research purposes only. Always consult a healthcare professional before starting any supplement regimen. ROI is modelled at $100,000 per quality-adjusted life year; see the methodology.